189 related articles for article (PubMed ID: 3044652)
1. Quantitation of human serum polymeric IgA, IgA1 and IgA2 immunoglobulin by enzyme immunoassay.
Jones C; Mermelstein N; Kincaid-Smith P; Powell H; Roberton D
Clin Exp Immunol; 1988 May; 72(2):344-9. PubMed ID: 3044652
[TBL] [Abstract][Full Text] [Related]
2. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.
van den Wall Bake AW; Daha MR; van der Ark A; Hiemstra PS; Radl J; van Es LA
Clin Exp Immunol; 1988 Oct; 74(1):115-20. PubMed ID: 3219797
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to polyclonal IgA, IgA1, and IgA2 and isotype-specific immune complexes in IgA nephropathy.
Jones CL; Hosking CS; Kincaid-Smith P; Powell HR; Richardson SC; Sennhauser FH; Roberton DM
J Clin Immunol; 1989 Jul; 9(4):306-12. PubMed ID: 2671010
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy.
van den Wall Bake AW; Daha MR; Radl J; Haaijman JJ; Van der Ark A; Valentijn RM; Van Es LA
Clin Exp Immunol; 1988 May; 72(2):321-5. PubMed ID: 3409549
[TBL] [Abstract][Full Text] [Related]
5. Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).
Sinico RA; Fornasieri A; Oreni N; Benuzzi S; D'Amico G
J Immunol; 1986 Jul; 137(2):536-41. PubMed ID: 3722816
[TBL] [Abstract][Full Text] [Related]
6. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
[TBL] [Abstract][Full Text] [Related]
7. Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver disease.
Newkirk MM; Klein MH; Katz A; Fisher MM; Underdown BJ
J Immunol; 1983 Mar; 130(3):1176-81. PubMed ID: 6822732
[TBL] [Abstract][Full Text] [Related]
8. Polymeric serum IgA and IgA subclasses in IgA nephropathy.
Jones C; Mermelstein N; Roberton D
Adv Exp Med Biol; 1987; 216B():1551-62. PubMed ID: 3425445
[No Abstract] [Full Text] [Related]
9. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
10. Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1--implications in IgA-mediated disease.
Almogren A; Kerr MA
Mol Immunol; 2008 Jan; 45(1):87-94. PubMed ID: 17606293
[TBL] [Abstract][Full Text] [Related]
11. Serum IgM-bound secretory component (sIgM) in liver diseases: comparative molecular state of the secretory component in serum and bile.
Delacroix DL; Jonard P; Dive C; Vaerman JP
J Immunol; 1982 Jul; 129(1):133-8. PubMed ID: 7086127
[TBL] [Abstract][Full Text] [Related]
12. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
[TBL] [Abstract][Full Text] [Related]
13. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
[TBL] [Abstract][Full Text] [Related]
14. [IgA nephropathy--IgA1 disease].
Maksić D; Marić M; Mijusković Z; Dimitrijević J; Kovacević Z; Jovanović D
Vojnosanit Pregl; 1996; 53(4):293-6. PubMed ID: 9229944
[TBL] [Abstract][Full Text] [Related]
15. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
[TBL] [Abstract][Full Text] [Related]
16. Development of immunoglobulin A in infancy and childhood.
Weemaes C; Klasen I; Göertz J; Beldhuis-Valkis M; Olafsson O; Haraldsson A
Scand J Immunol; 2003 Dec; 58(6):642-8. PubMed ID: 14636420
[TBL] [Abstract][Full Text] [Related]
17. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
Lue C; Tarkowski A; Mestecky J
J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
[TBL] [Abstract][Full Text] [Related]
18. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
19. Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children.
Simell B; Kilpi T; Käyhty H
Clin Exp Immunol; 2006 Mar; 143(3):543-9. PubMed ID: 16487254
[TBL] [Abstract][Full Text] [Related]
20. Polymeric IgA and immune complex concentrations in IgA-related renal disease.
Jones CL; Powell HR; Kincaid-Smith P; Roberton DM
Kidney Int; 1990 Aug; 38(2):323-31. PubMed ID: 2205751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
